For EBV-specific CD8+ T cells, several key T cell related signaling molecules like IL-2, ERK, platelet-derived growth factor (PDGF), Rel-A and TNF are predicted to be functionally less active in CLL (Fig. 4E). This evidence concerns the gene IL2 and B-cell chronic lymphocytic leukemia.